BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33929683)

  • 1. Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation.
    Lehmann L; Lo A; Knox KM; Barker-Haliski M
    Neurochem Res; 2021 Aug; 46(8):1895-1912. PubMed ID: 33929683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of presenilin 2 age-dependently alters susceptibility to acute seizures and kindling acquisition.
    Beckman M; Knox K; Koneval Z; Smith C; Jayadev S; Barker-Haliski M
    Neurobiol Dis; 2020 Mar; 136():104719. PubMed ID: 31862541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptic seizures in autosomal dominant forms of Alzheimer's disease.
    Cortini F; Cantoni C; Villa C
    Seizure; 2018 Oct; 61():4-7. PubMed ID: 30041064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptic seizures in AD patients.
    Larner AJ
    Neuromolecular Med; 2010 Mar; 12(1):71-7. PubMed ID: 19557550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From here to epilepsy: the risk of seizure in patients with Alzheimer's disease.
    Nicastro N; Assal F; Seeck M
    Epileptic Disord; 2016 Mar; 18(1):1-12. PubMed ID: 26907471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Setu JR; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Neurotox Res; 2020 Dec; 38(4):833-849. PubMed ID: 32556937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.
    Barker-Haliski M; Steve White H
    Neuropharmacology; 2020 May; 167():107750. PubMed ID: 31469995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic seizures induce sex-specific cognitive deficits with loss of presenilin 2 function.
    Knox KM; Beckman M; Smith CL; Jayadev S; Barker-Haliski M
    Exp Neurol; 2023 Mar; 361():114321. PubMed ID: 36634751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.
    Altuna M; Olmedo-Saura G; Carmona-Iragui M; Fortea J
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.
    DiFrancesco JC; Tremolizzo L; Polonia V; Giussani G; Bianchi E; Franchi C; Nobili A; Appollonio I; Beghi E; Ferrarese C
    J Alzheimers Dis; 2017; 60(4):1267-1274. PubMed ID: 28968234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy in Early Onset Alzheimer's Disease.
    Haoudy S; Jonveaux T; Puisieux S; Epstein J; Hopes L; Maillard L; Aron O; Tyvaert L
    J Alzheimers Dis; 2022; 85(2):615-626. PubMed ID: 34864663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilepsy and Alzheimer's Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies.
    Leo A; Tallarico M; Sciaccaluga M; Citraro R; Costa C
    Curr Neuropharmacol; 2022; 20(11):2029-2033. PubMed ID: 35524669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiseizure Medications in Alzheimer's Disease from Preclinical to Clinical Evidence.
    Bosco F; Guarnieri L; Rania V; Palma E; Citraro R; Corasaniti MT; Leo A; De Sarro G
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of epileptiform abnormalities and seizures in Alzheimer disease.
    Lam AD; Sarkis RA; Pellerin KR; Jing J; Dworetzky BA; Hoch DB; Jacobs CS; Lee JW; Weisholtz DS; Zepeda R; Westover MB; Cole AJ; Cash SS
    Neurology; 2020 Oct; 95(16):e2259-e2270. PubMed ID: 32764101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice.
    Sierksma AS; de Nijs L; Hoogland G; Vanmierlo T; van Leeuwen FW; Rutten BP; Steinbusch HW; Prickaerts J; van den Hove DL
    J Alzheimers Dis; 2016; 51(3):677-82. PubMed ID: 26890781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of epilepsy in patients with Alzheimer's disease.
    Giorgi FS; Guida M; Vergallo A; Bonuccelli U; Zaccara G
    Expert Rev Neurother; 2017 Mar; 17(3):309-318. PubMed ID: 27687685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach.
    Delabio R; Rasmussen L; Mizumoto I; Viani GA; Chen E; Villares J; Costa IB; Turecki G; Linde SA; Smith MC; Payão SL
    J Alzheimers Dis; 2014; 42(3):757-60. PubMed ID: 24927704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling seizures in patients with Alzheimer's disease.
    Tombini M; Boscarino M; Di Lazzaro V
    Expert Rev Neurother; 2023; 23(12):1131-1145. PubMed ID: 37946507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizures in Alzheimer's disease.
    Born HA
    Neuroscience; 2015 Feb; 286():251-63. PubMed ID: 25484360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.